BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 24091907)

  • 1. Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis.
    Truta B; Li DX; Mahadevan U; Fisher ER; Chen YY; Grace K; Velayos F; Terdiman JP
    Dig Dis Sci; 2014 Jan; 59(1):135-45. PubMed ID: 24091907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis.
    Coukos JA; Howard LA; Weinberg JM; Becker JM; Stucchi AF; Farraye FA
    Dig Dis Sci; 2012 Jun; 57(6):1544-53. PubMed ID: 22311367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The MYTHS of
    James SD; Hawkins AT; Um JW; Ballard BR; Smoot DT; M'Koma AE
    Jpn J Gastroenterol Hepatol; 2020; 3(2):. PubMed ID: 37584007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch.
    Werner L; Sturm A; Roggenbuck D; Yahav L; Zion T; Meirowithz E; Ofer A; Guzner-Gur H; Tulchinsky H; Dotan I
    J Crohns Colitis; 2013 Dec; 7(11):e522-32. PubMed ID: 23639628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis.
    Dendrinos KG; Becker JM; Stucchi AF; Saubermann LJ; LaMorte W; Farraye FA
    J Gastrointest Surg; 2006; 10(7):1060-4. PubMed ID: 16843878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Family history and serology predict Crohn's disease after ileal pouch-anal anastomosis for ulcerative colitis.
    Melmed GY; Fleshner PR; Bardakcioglu O; Ippoliti A; Vasiliauskas EA; Papadakis KA; Dubinsky M; Landers C; Rotter JI; Targan SR
    Dis Colon Rectum; 2008 Jan; 51(1):100-8. PubMed ID: 18085333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serologic responses in indeterminate colitis patients before ileal pouch-anal anastomosis may determine those at risk for continuous pouch inflammation.
    Hui T; Landers C; Vasiliauskas E; Abreu M; Dubinsky M; Papadakis KA; Price J; Lin YC; Huiying Y; Targan S; Fleshner P
    Dis Colon Rectum; 2005 Jun; 48(6):1254-62. PubMed ID: 15868228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-Term Bowel Function and Fate of the Ileal Pouch After Restorative Proctocolectomy in Patients With Crohn's Disease: A Systematic Review With Meta-Analysis and Metaregression.
    Pellino G; Vinci D; Signoriello G; Kontovounisios C; Canonico S; Selvaggi F; Sciaudone G
    J Crohns Colitis; 2020 Mar; 14(3):418-427. PubMed ID: 31412119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease.
    Le Q; Melmed G; Dubinsky M; McGovern D; Vasiliauskas EA; Murrell Z; Ippoliti A; Shih D; Kaur M; Targan S; Fleshner P
    Inflamm Bowel Dis; 2013 Jan; 19(1):30-6. PubMed ID: 22467562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ileal Pouch Anal Anastomosis (IPAA) for colitis; development of Crohn's and Pouchitis.
    Kolbeinsson HM; Wall T; Bayat A; Luchtefeld M; Ogilvie JW
    Am J Surg; 2022 Jul; 224(1 Pt B):453-458. PubMed ID: 35086697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pyloric gland metaplasia: Potential histologic predictor of severe pouch disease including Crohn's disease of the pouch in ulcerative colitis.
    Li H; Arslan ME; Lee EC; Qualia CM; Mikula MW; Fu Z; Petchers A; Arker SH; Kmeid M; Boguniewicz A; Lee H
    Pathol Res Pract; 2021 Apr; 220():153389. PubMed ID: 33640710
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Redo IPAA After a Failed Pouch In Patients With Crohn's Disease: Is It Worth Trying?
    Lavryk OA; Stocchi L; Shawki S; Aiello A; Church JM; Steele SR; Hull TL
    Dis Colon Rectum; 2020 Jun; 63(6):823-830. PubMed ID: 32384407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcomes of Ileoanal Pouch Anastomosis in Pediatric Ulcerative Colitis Are Worse in the Modern Era: A Time Trend Analysis Outcomes Following Ileal Pouch-Anal Anastomosis in Pediatric Ulcerative Colitis.
    Runde J; Erondu A; Akiyama S; Traboulsi C; Rai V; Glick LR; Yi Y; Ollech JE; Cohen RD; Skowron KB; Hurst RD; Umanskiy K; Shogan BD; Hyman NH; Rubin MA; Dalal SR; Sakuraba A; Pekow J; Chang EB; Rubin DT
    Inflamm Bowel Dis; 2022 Sep; 28(9):1386-1394. PubMed ID: 35040964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Different clinical characteristics in Hispanic and non-Hispanic whites with ileal pouch-anal anastomosis: a case-control study.
    Lian L; Moore L; Wu XJ; He XS; Lan P; Shen B
    Inflamm Bowel Dis; 2011 Apr; 17(4):1003-7. PubMed ID: 20722060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crohn's-like complications in patients with ulcerative colitis after total proctocolectomy and ileal pouch-anal anastomosis.
    Goldstein NS; Sanford WW; Bodzin JH
    Am J Surg Pathol; 1997 Nov; 21(11):1343-53. PubMed ID: 9351572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De Novo Crohn's Disease of the Pouch in Children Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis.
    Jarchin L; Spencer EA; Khaitov S; Greenstein A; Jossen J; Lai J; Dunkin D; Pittman N; Benkov K; Dubinsky MC
    J Pediatr Gastroenterol Nutr; 2019 Oct; 69(4):455-460. PubMed ID: 31136563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pre-colectomy appendectomy and risk for Crohn's disease in patients with ileal pouch-anal anastomosis.
    Liu Z; Lu H; Kiran RP; Ni R; Remzi FH; Shen B
    J Gastrointest Surg; 2012 Jul; 16(7):1370-8. PubMed ID: 22528574
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis.
    Fleshner P; Ippoliti A; Dubinsky M; Vasiliauskas E; Mei L; Papadakis KA; Rotter JI; Landers C; Targan S
    Clin Gastroenterol Hepatol; 2008 May; 6(5):561-8. PubMed ID: 18378498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumour necrosis factor therapy is associated with de novo Crohn's disease after ileal pouch-anal anastomosis.
    Truong A; Zaghiyan KN; Mirocha J; Melmed GY; McGovern DPB; Syal G; Ha CY; Targan SR; Fleshner PR
    Colorectal Dis; 2021 Sep; 23(9):2416-2424. PubMed ID: 34157179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of tolerance to glycoprotein 2 isoforms 1 and 4 is associated with Crohn's disease of the pouch.
    Cummings D; Cruise M; Lopez R; Roggenbuck D; Jairath V; Wang Y; Shen B; Rieder F
    Aliment Pharmacol Ther; 2018 Dec; 48(11-12):1251-1259. PubMed ID: 30411391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.